home > drugs a-z list > focalin xr (dexmethylphenidate hydrochloride) drug center > focalin xr (dexmethylphenidate hydrochloride) drug - overdosage and contraindications

Signs and Symptoms

Signs and symptoms of acute methylphenidate overdosage, resulting principally from overstimulation of the CNS and from excessive sympathomimetic effects, may include the following: vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions (may be followed by coma), euphoria, confusion, hallucinations, delirium, sweating, flushing, headache, hyperpyrexia, tachycardia, palpitations, cardiac arrhythmias, hypertension, mydriasis, and dryness of mucous membranes.

Poison Control Center

The physician may wish to consider contacting a poison control center for up-to-date information on the management of overdosage with methylphenidate.

Recommended Treatment

As with the management of all overdosage, the possibility of multiple drug ingestion should be considered.

When treating overdose, practitioners should bear in mind that there is a prolonged release of dexmethylphenidate from Focalin XR (dexmethylphenidate hydrochloride) .

Treatment consists of appropriate supportive measures. The patient must be protected against self-injury and against external stimuli that would aggravate overstimulation already present. Gastric contents may be evacuated by gastric lavage as indicated. Before performing gastric lavage, control agitation and seizures if present and protect the airway. Other measures to detoxify the gut include administration of activated charcoal and a cathartic. Intensive care must be provided to maintain adequate circulation and respiratory exchange; external cooling procedures may be required for hyperpyrexia.

Efficacy of peritoneal dialysis for Focalin overdosage has not been established.

Agitation

Focalin XR (dexmethylphenidate hydrochloride) is contraindicated in patients with marked anxiety, tension, and agitation, since the drug may aggravate these symptoms.

Hypersensitivity to Methylphenidate

Focalin XR (dexmethylphenidate hydrochloride) is contraindicated in patients known to be hypersensitive to methylphenidate, or other components of the product.

Glaucoma

Focalin XR (dexmethylphenidate hydrochloride) is contraindicated in patients with glaucoma.

Tics

Focalin XR (dexmethylphenidate hydrochloride) is contraindicated in patients with motor tics or with a family history or diagnosis of Tourette's syndrome [see ADVERSE REACTIONS].

Monoamine Oxidase Inhibitors

Focalin XR (dexmethylphenidate hydrochloride) is contraindicated during treatment with monoamine oxidase inhibitors, and also within a minimum of 14 days following discontinuation of treatment with a monoamine oxidase inhibitor (hypertensive crises may result).

Last reviewed on RxList: 12/27/2010
This monograph has been modified to include the generic and brand name in many instances.